Conference Abstracts

1. Seguin-Devaux C., Hofstra M.L., Hunewald O., Alexiev I., Bobkova M., Descamps D., Griskevicius A., de Jong D.M.C., Kostrikis L.G., Lambert C., Liitsola K., Mor O., Paraskevis D., Parczewski M., Poljak M., Ruelle J., Servais J-Y., Zidovec Lepej S., Nijhuis M., Wensing A.M.J., Boucher C.A.B. on behalf of the SPREAD Program. European Surveillance of HIV Drug Resistance to NRTI, NNRTI and INSTI in Newly Diagnosed Individuals Using Next-Generation Sequencing. 17th European Meeting on HIV & Hepatitis. Rome, Italy, 2019.


2. Chrysostomou A., Topcu C., Stylianou D., Ioannou M., Ioannou L., Hezka J., Demetriades I., and Kostrikis L.G. A Touchdown PCR Assay of HIV-1 Pol for a Comprehensive Genotypic Drug Resistance Analysis of Patients Infected with Group M HIV-1 strains. 17th European Meeting on HIV & Hepatitis. Rome, Italy, 2019.


3. Kostrikis L.G. Phage-Display Systems for Development of Novel Vaccines. International Conference on Immunology and Vaccination. Rome, Italy 2019.


4. Kostrikis L.G. Longitudinal HIV-1 Phylogenetic and Phylodynamic Transmission Analyses in Cyprus: The Cypriot HIV-1 Transmission Cohort Study (CHICS). PCS 4th Annual Health Care Congress-2019. Marrakech, Morocco, 2019.


5. Kostaki E., Stylianou D.C., Mavrikaki S., Hexka J., Chrysostomou A., Demetriades I., Paraskevis D. and Kostrikis L. G. Phylogeographic Analysis of HIV-1 Subtype A Infection in Cyprus: The Cyprus HIV-1 Transmission Cohort Study (CHICS) from 1986 to 2012. 16th European Meeting on HIV & Hepatitis. Rome, Italy, 2018.


6. Marshall A.D., Cunningham E.B., Nielsen S., Aghemo A., Alho H., Backmund M., Bruggmann P., Dalgard O., Seguin-Devaux C., Flisiak R. Foster G.R., Gheorghe L., Goldberg D., Goulis I., Hickman M., Hoffmann P., Jancorienė L., Jarcuska P., Kåberg M., Kostrikis L.G., Makara M., Maimets M.22, Marinho R.T., Matičič M., Norris S., Ólafsson S., Øvrehus A., Pawlotsky J.M., Pocock J., Robaeys G., Roncero C., Simonova M., Sperl J., Tait M., Tolmane I., Tomaselli S., van der Valk M., Vince A., Dore G.J., Lazarus J.V., Grebely J., International Network on Hepatitis in Substance Users (INHSU). Restrictions for Reimbursement of Interferon-Free Direct-Acting Antiviral Therapies for HCV Infection in Europe. Canadian Liver Meeting. Toronto, Canada, 2018.


7. Demetriades I. and Kostrikis L.G. Monitoring of HIV-1 Drug Resistance Mutations in Newly Diagnosed Patients in Cyprus (2010-2012). Infectious Diseases Week 2017. San Diego, CA, USA, 2017.


8. Kostrikis L. G. HIV Disease: From Biology to Chemotherapeutics and Beyond. 5th International Bio-Medical Scientific Cyprus Congress. Nicosia, Cyprus, 2017.


9. Hezka J., Stylianou D., Kostaki E.G., Andreou M., Kousiappa I., Demetriades I. and Kostrikis L.G. Molecular Epidemiology of Newly Diagnosed HIV-1 Infected Patients in Cyprus (2010-2012) Reveals Active Transmission Networks Among Young Men Having Sex with Men and Low Transmitted Drug Resistance. 15th European Meeting on HIV & Hepatitis. Rome, Italy, 2017.


10. Hofstra L.M., Sauvageot N., Albert J., Alexiev I., Struck D., Van de Vijver D.A.M.C., Åsjö B., Beshkov D., Coughlan S., Descamps D., Garcia F., Gomes P., Griskevicius A., Hamouda O., Horban A., Kolupajeva T., Kostrikis L.G., Liitsola K., Linka M., Mor O., Nielsen C., Otelea D., Paraskevis D., Parczewski M., Paredes R., Poljak M., Puchhammer-Stöckl E., Ruelle J., Sönnerborg A., Staneková D., Stanojevic M., Van Laethem K., Yalcinkaya T., Zazzi M., Zidovec Lepej S., Schmit J-C., Boucher C.A.B. and Wensing A.M.J. on behalf of the SPREAD program Interactive Monitoring of HIV Drug Resistance Mutations in Newly Diagnosed Patients in Europe. 27th European Congress of Clinical Microbiology and Infectious Diseases. Vienna, Austria, 2017.


11. Kostrikis L. G. Development of Vaccines Using Genetically Engineered Inoviruses. 16th International Conference on Vaccines. Berlin, Germany, 2017.


12. Kostrikis L. G. Next-Generation Approaches to Designing HIV-1 Vaccines. 12th Global Vaccines and Vaccination Summit. Dubai, UAE, 2016.


13. Kostrikis L. G. Engineering Antigen-Displayed Phage as Vaccines. 4th World Congress on Targeting Infectious Diseases. Paris, France, 2016.


14. Oikonomopoulou M., Demetriou V., Kostrikis L. G. And Paraskevis D. Re-Analysis of Unassigned Hepatitis C Virus (HCV) Strain CYHCV025: Evidence of a Highly Divergent Lineage within Genotype 1. International Symposium HIV & Emerging Infectious Diseases (ISHEID) 2016 Congress. Marseille, France, 2016.


15. Pineda-Peña A-C, Theys K., Hezka J., Kousiappa I., Andreou M., Demetriades I.4, Abecasis A. B. and Kostrikis L. G. Molecular Epidemiology of HIV-1 Infection in Cyprus: Onward Transmission is Predominantly Driven by Young Adults. International Symposium HIV & Emerging Infectious Diseases (ISHEID) 2016 Congress. Marseille, France, 2016.


16. Paraskevis D., Demetriou V., Oikonomopoulou M., Mamais I., Hezka J., Andoniadou M., Andreou I., Stylianou D. C., and Kostrikis, L. G. A Phylogeographic Analysis of HCV Viral Sequences from the General Population and High-Risk Groups Including Intravenous Drug Users Attending Therapy Programs in Cyprus. 14th European Meeting on HIV & Hepatitis. Rome, Italy, 2016.


17. Pineda-Peña A-C., Theys K., Hezka J., Kousiappa I., Andreou M., Demetriades I., Stylianou D.C., Abecasis A.B., Kostrikis L.G. and on the behalf of the SPREAD Program of ESAR. Transmission Patterns of Concurrent HIV-1 Subtype Epidemics Circulating in Cyprus: A Phylodynamic Analysis. 14th European Meeting on HIV & Hepatitis. Rome, Italy, 2016.


18. Kostaki E., Flampouris A., Angelis K., Mamais I., Albert J., AltzerinakouM. A., Lawyer G., Hamouda O., Struck D., Vercauteren J., Wensing A-M., Alexiev I., Åsjö B., Balotta C, Camacho R.J., Coughlan S., Doulis I., Griskevicius A., Grossman Z., Hatzakis A., Horban A., Kikeri M., Kostrikis L.G., Lepej S. J., Liitsola K., Linka M., Markozanes G., Magiorkinis G., Nielsen C., Otelea D., Paredes R., Poljak M., Puchhammer-Stöckl E., Schmit J-C., Sönnerborg A., Staneková D., Stanojevic M., Boucher C. A. B. on behalf of the SPREAD program, Nikolopoulos G., Vasylyeva T., Friedman S. R., van de Vijver D.A.M.C., Angarano G., Chaix M-L., de Luca A., Korn K., Loveday C., Soriano V., Yerly S., Zazzi M., Vandamme A-M. And Paraskevis D. Dating Regional Subtype B Subepidemics: Evidence for Earliest Introduction in Western Europe and Caribbean. 14th European Meeting on HIV & Hepatitis. Rome, Italy, 2016.


19. Hofstra L. M., Sauvageot N., Albert J., Alexiev I., Struck S., Van de Vijver D.A.M.C., Åsjö B., Beshkov D., Coughlan S., Descamps D., Garcia F., Gomes P., Griskevicius A., Hamouda O., Horban A., Kolupajeva T., Kostrikis L.G., Liitsola K., Linka M., Mor O., Nielsen C., Otelea D., Paraskevis D., Parczewski M., Paredes R., Poljak M., Puchhammer-Stöckl E., Ruelle J., Sönnerborg A., Staneková D., Stanojevic M., Van Laethem K., Yalcinkaya T., Zazzi M., Zidovec Lepej S., Schmit J-C., Boucher C.A.B. and Wensing A.M.J on behalf of the SPREAD Program. Transmission of HIV Resistance Mutations Varies Regionally in Europe. 14th European Meeting on HIV & Hepatitis. Rome, Italy, 2016.


20. Hofstra L. M., Geretti A. M., Boucher C. A. B., De Luca A., Descamps D., Harrigan P. R., Schmit J. C., Vandekerckhove L., Wensing A. M. J. on behalf of the European Guidance Group on Clinical Management of HIV-1 Low Level Viremia. Consensus Guidance on Clinical Management of Low-Level Plasma HIV-1 RNA Rebound after Initial Suppression. 15th European AIDS Conference (European AIDS Clinical Society, EACS). Barcelona, Spain, 2015.


21. Hofstra L.M., Sauvageot N., Albert J., Alexiev I., Struck D., Van de Vijver D.6, Åsjö B., Beshkov D., Camacho R., Coughlan S.,Descamps D., Garcia F., Griskevicius A., Hamouda O., Horban A., Kolupajeva T., Kostrikis L. G., Liitsola K., Linka M., Mor O., Nielsen C., Otelea D., Paraskevis D., Parczewski M., Paredes R., Poljak M., Puchhammer-Stöckl E., Ruelle J., Sönnerborg A., Staneková D., Stanojevic M., Vandamme A., Yalcinkaya T., Zazzi M., Zidovec Lepej S., Schmit J-C., Boucher C. A. B. and Wensing A. M. J. on behalf of the SPREAD Program. Regional Differences in Transmission of HIV Drug Resistance Mutations in Europe. 15th European AIDS Conference (European AIDS Clinical Society, EACS). Barcelona, Spain, 2015.


22. Kostrikis L. G. Novel Vaccines Utilizing Antigen-Displayed Inoviral Vectors. 7th Global Summit on Vaccines and Vaccination. Dubai, UAE, 2015.


23. Mamais I., Albert J., Angelis K., Magiorkinis G., Beloukas A., Hatzakis A., Hamouda O., Struck D., Vercauteren J., Wensing A.M.J., Alexiev I., Åsjö B., Balotta C., Camacho R.J., Coughlan S., Griskevicius A., Grossman Z., Horban A., Kostrikis L.G., Lepej S., Liitsola K., Linka M., Nielsen C., Otelea D., Paredes R., Poljak M., Puchhammer-Stöckl E., Schmit J.C., Sönnerborg A., Staneková D., Stanojevic M., Boucher C. A. B., the SPREAD programme, Vandamme A-M. and Paraskevis D. The Global Spread of HIV-1 Subtype A Epidemic: A Phylogeographic Analysis. 13th European Meeting on HIV & Hepatitis –Treatment Strategies & Antiviral Drug Resistance. Barcelona, Spain, 2015.


24. Hofstra L. M., Boucher C. A. B., Descamps D., Geretti A. M., Harrigan P. R., Vandekerckhove L., Wensing A. M. J. on behalf of the European Guidance Group on clinical management of HIV-1 low level viremia. European Guidance on Clinical Management of HIV Low Level Viremia. 13th European Meeting on HIV & Hepatitis –Treatment Strategies & Antiviral Drug Resistance. Barcelona, Spain, 2015.


25. Magiorkinis G., Angelis K., Mamais I., Katzourakis A., Hatzakis A., Albert J., Lawyer G., Hamouda O., Struck D., Vercauteren J., Wensing A.M.J., Alexiev I., Åsjö B., Balotta C., Camacho R.J., Coughlan S., Griskevicius A., Grossman Z., Horban A., Kostrikis L.G., Liitsola K., Linka M., Nielsen C., Otelea D., Paredes R., Poljak M., Puchhammer-Stöckl E., Schmit J.C., Sönnerborg A., Staneková D., Stanojevic M. and Boucher C.A.B., Nikolopoulos G., Friedman S.R., Vandamme A-M. and Paraskevis D. Geopolitical Effects in the Epidemiology of HIV-1 Subtype B. 2015 Conference on Retroviruses and Opportunistic Infecetions (CROI). Seattle, USA, 2015.


26. Kostrikis L. G. HIV-1 Neutralizing Epitopes Displayed on the Surface of Inoviruses as Vaccine Immunogens to Raise Antiviral Antibody Responses. International Symposium HIV & Emerging Infectious Diseases (ISHEID) 2014 Congress. Marseille, France, 2014.


27. Mamais I., Albert J., Magiorkinis G., Hatzakis A., Hamouda O., Struck D., Vercauteren J., Wensing A. M. J., Alexiev I., Asjo B., Balotta C., Camacho R. J. Coughlan S., Griskevicius A., Grossman Z., Horban A., Kostrikis L. G., Lepej S., Liitsola K., Linka M., Nielsen C., Otelea D., Paredes R., Poljak M., Puchhammer-Stockl E., Schmit J. C., Sonnerborg A., Stranekova D., Stranojevic M., Boucher C. A. B. On behalf of the SPREAD program, Vandamme A-M. And Paraskevis D. The Global Spread of HIV-1 CRF_AE Epidemic: A Phylogeographic Analysis. 20th International AIDS Conference. Melbourne, Australia, 2014.


28. Magiorkinis G., Angelis K., Mamais I., Katzourakis A., Hatzakis A., Albert J., Lawyer G., Hamouda O., Struck D., Vercauteren J., Wensing A.M.J., Alexiev I., Åsjö B., Balotta C., Camacho R.J., Coughlan S., Griskevicius A., Grossman Z., Horban A., Kostrikis L.G., Liitsola K., Linka M., Nielsen C., Otelea D., Paredes R., Poljak M., Puchhammer-Stöckl E., Schmit J.C., Sönnerborg A., Staneková D., Stanojevic M. and Boucher C.A.B. on behalf of the SPREAD program, Nikolopoulos G., Friedman S.R., Vandamme A-M. and Paraskevis D. The Geopolitical Evolution of HIV-1 Subtype B Epidemic Epidemic. 20th International AIDS Conference. Melbourne, Australia, 2014.


29. Hofstra L.M., Sauvageot N., Albert J., Alexiev I., Garcia F., Struck D., van de Vijver D., Åsjö B., Balotta C., Beshkov D., Camacho R.J., Coughlan S., Griskevicius A., Hamouda O., Horban A., Kolupajeva T., Kostrikis L.G., Kücherer C., Liitsola K., Linka M., Mor O., Nielsen C., Otelea D., Paraskevis D., Paredes R., Parruti G., Poljak M., Puchhammer-Stöckl E., Sönnerborg A., Staneková D., Stanojevic M., Vandamme A-M., Zidovec Lepe S., Boucher C.A.B., Schmit J.C. and Wensing A.M.J. on behalf of the SPREAD program. Prevalence of Resistance Mutations Associated with Decreased Susceptibility to Rilpivirine in Antiretroviral Naive Patients from Europe. 12th European Meeting on HIV & Hepatitis –Treatment Strategies & Antiviral Drug Resistance. Barcelona, Spain, 2014.


30. Casadellà M., Ham P.M., van Kessel A., Noguera-Julian M., Pou C., Garcia F., Struck D., Alexiev I., Åsjö B., Kostrikis L.G., Kücherer C., Liitsola K., Linka M., Nielsen C., Otelea D., Paraskevis D., Poljak M., Puchhammer-Stöckl E., Staneková D., Stanojevic M., Vandamme A-M., Zidovec Lepej S., Clotet B., Boucher C., Paredes R. and Wensing A.M. on behalf of the SPREAD programme. Primary Resistance to Integrase Strand-Transfer Inhibitors in Europe. 12th European Meeting on HIV & Hepatitis –Treatment Strategies & Antiviral Drug Resistance. Barcelona, Spain, 2014.


31. Kostrikis L.G., van de Vijver D. and Kousiappa I. HIV-1 Dissemination in Cyprus, the Eastern European Frontier: Phylogeographic and Temporal Dynamic Analyses of Viral Sequences Nearly a Decade. 12th European Meeting on HIV & Hepatitis –Treatment Strategies & Antiviral Drug Resistance. Barcelona, Spain, 2014.


32. Pineda-Peña A-C., Schrooten Y., Vinken L., Ferreira F., Li G. , Sequeira Trovão N., Khouri R., Derdelinckx I., de Munter P., Kücherer C., Kostrikis L.G., Nielsen C., Liitsola K., Balotta C., Wensing A.M.J., Stanojevic M., Paredes R., Albert J., Boucher C.A.B., Gomez-Lopez A., van Wijngaerden E., van Ranst M., Vercauteren J., van Laethem K. and Vandamme A-M. Predictors of HIV-1 Transmitted Drug Resistance and Transmission Networks in the Leuven Cohort. 12th European Meeting on HIV & Hepatitis –Treatment Strategies & Antiviral Drug Resistance. Barcelona, Spain, 2014.


33. Hofstra L. M., D. Pilalas D., Alexiev I., F. Garcia F., Hamouda O., Staneková D., Struck D., Albert J., Åsjö B., Balotta C., Beshkov D., Camacho R. J, Coughlan S., Griskevicius A., Horban A., Kostrikis L. G., Kücherer C., Liitsola K., Linka M., Mor O., Nielsen C., Otelea D., Paraskevis D., Paredes R., Poljak M., Puchhammer-Stöckl E., Stanojevic M., Vandamme A-M, Zidovec Lepej S, Boucher C. A. B., Wensing A. M. J. and Schmit J. C. on behalf of the SPREAD program. Migrants Have a Higher Risk of Presenting in an Advanced Stage of HIV Infection Compared to Natives, Particularly Heterosexual and non-European Migrants. 5th European Conference on Migrant and Ethnic Minority and Healthcare. Granada, Spain, 2014.


34. Casadella M., Ham P. M., Noguera-Julian M., Struck D., Clotet B., Boucher C. A. B., Paredes R., Wensing A. M. J. on behalf of the SPREAD program. Primary Resistance to Integrase Strand Inhibitors in Europe. 2014 Conference on Retroviruses and Opportunistic Infecetions (CROI). Boston, USA, 2014.


35. Hofstra L. M., D. Pilalas D., Alexiev I., F. Garcia F., Hamouda O., Staneková D., Struck D., Albert J., Åsjö B., Balotta C., Beshkov D., Camacho R. J, Coughlan S., Griskevicius A., Horban A., Kostrikis L. G., Kücherer C., Liitsola K., Linka M., Mor O., Nielsen C., Otelea D., Paraskevis D., Paredes R., Poljak M., Puchhammer-Stöckl E., Stanojevic M., Vandamme A-M, Zidovec Lepej S, Boucher C. A. B., Wensing A. M. J. and Schmit J. C. on behalf of the SPREAD program. Europe-wide Increase of Early Detection of HIV-1 MSM, but Additional Strategies Are Needed for Other Risk Groups. 14th European AIDS Clinical Society (EACS) Conference. Brussels, Belgium, 2013.


36. Hofstra L. M., Sauvageot N., Albert J., Alexiev I., Garcia F., Struck D., Vercauteren J., Van de Vijver D., Åsjö B., Balotta C., Beshkov D., Camacho R. J., Coughlan S., Griskevicius A., Hamouda O., Horban A., Kolupajeva T., Kostrikis L. G., Kücherer C., Liitsola K., Linka M., Mor O., Nielsen C., Otelea D., Paraskevis D., Paredes R., Poljak M., Puchhammer-Stöckl E., Sönnerborg A., Staneková D., Stanojevic M., Vandamme A-M., Zidovec Lepej S., Boucher C. A. B., Schmit J. C. And Wensing A. M. J. on behalf of the SPREAD program. The Burden of Transmitted Drug Resistance in Clinical Practice in Europe is Increasing over Time Despite a Stable Prevalence. 8th International Workshop on HIV Transmision. Barcelona, Spain, 2013.


37. Hofstra L. M., Sauvageot N., Albert J., Alexiev I., Garcia F., Struck D., Vercauteren J., Van de Vijver D., Åsjö B., Balotta C., Beshkov D., Camacho R. J., Coughlan S., Griskevicius A., Hamouda O., Horban A., Kolupajeva T., Kostrikis L. G., Kücherer C., Liitsola K., Linka M., Mor O., Nielsen C., Otelea D., Paraskevis D., Paredes R., Poljak M., Puchhammer-Stöckl E., Sönnerborg A., Staneková D., Stanojevic M., Vandamme A-M., Zidovec Lepej S., Boucher C. A. B., Schmit J. C. And Wensing A. M. J. on behalf of the SPREAD program. Increasing Number of HIV-1 Diagnoses with Transmitted Drug Resistance across Europe Despite Stable Prevalence. 14th European AIDS Clinical Society (EACS) Conference. Brussels, Belgium, 2013.


38. Antoniadou Z., Kousiappa I., Mamais I., Hezka J., Pilalas D., Skoura L., Metallidis S., Nikolaidis P., Malisiovas N. and Kostrikis L. G. Genetic Characterization of HIV-1 Strains and Cellular HIV-1 DNA Quantification from Newly Diagnosed Antiretroviral Naive Individuals in Northern Greece: Evidence of High Prevalence of Transmitted Drug Resistance Among MSM. 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention. Kuala-Lumpur, Malaysia, 2013.


39. Kousiappa I., Hezka J., Andreou M., Demetriades I. and Kostrikis L. G. The Molecular Epidemiology of HIV-1 Infection in Cyprus from 2010 to 2012 Revealed an Ongoing Influx of Different HIV-1 Lineages and Low Transmitted Drug Resistance Among Antiretroviral Naive Infected Individuals. 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention. Kuala-Lumpur, Malaysia, 2013.


40. Antoniadou Z., Kousiappa I., Mamais I., Hezka J., Pilalas D., Skoura L., Metallidis S., Nikolaidis P., Malisiovas N. and Kostrikis L. G. Genetic Characterization of HIV-1 Strains and Cellular HIV-1 DNA Quantification of Newly Diagnosed Antiretroviral Naive Patients in Northern Greece. 11th European Meeting on HIV and Hepatitis Workshop. Rome, Italy 2013.


41. Kousiappa I., Hezka J., Demetriades I. and Kostrikis L. G. Ongoing Influx of Different HIV-1 Lineages and Low Transmitted Drug Resistance Among Antiretroviral Naive Infected Individuals in Cyprus (2010-2012). 11th European Meeting on HIV and Hepatitis Workshop. Rome, Italy 2013.


42. Iacovides D., Hezka J., Savvopoulou N., Chrysanthou A. and Kostrikis L. G. Molecular Epidemiology and Genetic Analysis of HCV Infection in Cyprus within an Intravenous Drug User Study Cohort . 17th International Symposium on HIV and Emerging Infectious Diseases. Marseille, France, 2012.


43. Antoniadou Z., Kousiappa I., Hezka J., Skoura L., Metallidis S., Nicolaidis P., Malisiovas N. And Kostrikis L. G. Molecular Epidemiology and Drug Resistance Prevalence of Strains from Newly-Diagnosed HIV-1 Patients in Northern Greece. 17th International Symposium on HIV and Emerging Infectious Diseases. Marseille, France, 2012.


44. Iacovides D., Hezka J., Savvopoulou N., Chrysanthou A. and Kostrikis L. G. Genetic Studies of HCV Isolates from Intravenous Drug Users in Cyprus. 10th European Meeting on HIV and Hepatitis. Barcelona, Spain, 2012.


45. Kousiappa I., Lazarou Y., Othonos K. M. and Kostrikis L. G. Influx of Uncommon HIV-1 Strains from Eastern Europe and Identification of a New Unique Recombinant Strain Among Young Cypriot MSM in Cyprus. 17th International Symposium on HIV and Emerging Infectious Diseases. Marseille, France, 2012.


46. Frentz D., van de Vijver D.A.M.C., Abecasis A., Albert J., Bruun Jørgensen L., Hamouda O., Kücherer C., Schmit J.-C., Struck D., Vandamme A.-M., Vercauteren J., Åsjö B., Balotta C., Beshkov D., Camacho R., Coughlan S., Griskevicius A., Grossman, A. Horban, T. Kolupajeva, K. Korn, L. Kostrikis, K. Liitsola, M. Linka, D. Otelea Z., Paraskevis D., Paredes R., Poljak M., Puchhammer-Stöckl E., Schuurman R., Sönnerborg A., Staneková D., Stanojevic M., Zidovec Lepej S., Wensing A.M.J., Boucher C.A.B., on behalf of the SPREAD programme. Transmission of HIV Resistance to Non-Nucleoside RT Inhibitors is Rising in Europe. 13th European AIDS Conference. Belgrade, Serbia, 2011.


47. Vandekerckhove L. P. R. , Wensing A. M. J. , Kaiser R., Brun-Vézinet F., Clotet B., De Luca A., Dressler S., Garcia F., Geretti A. M., Klimkait T., Korn K., Masquelier B., Perno C. F., Schapiro J. M., Soriano V., Sönnerborg A. M., Vandamme A. M., Verhofstede C., Walter H., Zazzi M. andBoucher C. A. B. on behalf of the European Consensus Group on Clinical Management of Tropism Testing. Consensus Statement of the European Guidelines on Clinical Management of HIV-1 Tropism Testing vs 1.0. 9th European Workshop on HIV & Hepatitis -Treatment Strategies & Antiviral Drug Resistance. Pafos, Cyprus, 2011.


48. Demetriou V. L., Kyriakou E., Chimonides S., Evgeniou A., Hadjigeorgiou-Vounou E., Hadjivasileiou E., Koliou-Mazeri M., Papakyriakou P., Petsas L., Potamitis G. And Kostrikis L. G. 9th European Workshop on HIV & Hepatitis -Treatment Strategies & Antiviral Drug Resistance. Pafos, Cyprus, 2011.


49. Kousiappa I., Achilleos C., Hezka J., Othonos K., Demetriades I. And Kostrikis L. G. Continued Influx of Different Lineages of HIV-1 Virus in Cyprus: A 3-Year Molecular Epidemiology Study 2007 – 2009. 9th European Workshop on HIV & Hepatitis -Treatment Strategies & Antiviral Drug Resistance.Pafos, Cyprus, 2011.


50. Frentz D., on behalf of the SPREAD Programme of the EuropeHIVResistance Network. Recent Dynamics of Transmitted Drug Resistance in Europe: SPREAD Program 2006 – 2007. 9th European Workshop on HIV & Hepatitis -Treatment Strategies & Antiviral Drug Resistance. Pafos, Cyprus, 2011.


51. Abecasis A. B.,Wensing A. M. J., Vercauteren J., Paraskevis D., Vijver D., Theys K., Albert J., Schmit J-C., Kücherer C., Hamouda O., Struck D., Åsjö B., Balotta C., Bruun Jørgensen L., Camacho R., Coughlan S., Grossman Z., Horban A., Kostrikis L. G., Liitsola K., Linka M., Paredes R., Poljak M., Puchhammer-Stöckl E., Sönnerborg A., Stanekova D., Stanojevic M., Boucher C. and Vandamme A-M. on behalf of the SPREAD Programme of the European Society for Antiviral Resistance and the EuropeHIVResistance Network. Genetic Diversity of HIV-1 in Europe and its Demographic Determinants (2002 – 2005). 9th European Workshop on HIV & Hepatitis -Treatment Strategies & Antiviral Drug Resistance. Paphos, Cyprus, 2011.


52. Achilleos C., Kousiappa I. and Kostrikis L. G. Genetic Characterization of Near-Full Length HIV-1 Sequences Derived from Sub-Sahara Africa in Cyprus. 5th Congress of Clinical Chemistry and Laboratory Medicine. Limassol, Cyprus, 2011.


53. Kyriakou E., Demetriou V. L. And Kostrikis L. G. Optimization of a Protocol for Near-Full Characterization of Two Putative Hepatitis C Virus 2k/1b Recombinants. 5th Congress of Clinical Chemistry and Laboratory Medicine. Limassol, Cyprus, 2011.


54. Vandekerckhove L. P. R. , Wensing A. M. J. , Kaiser R., Brun-Vézinet F., Clotet B., De Luca A., Dressler S., Garcia F., Geretti A. M., Klimkait T., Korn K., Masquelier B., Perno C. F., Schapiro J. M., Soriano V., Sönnerborg A. M., Vandamme A. M., Verhofstede C., Walter H., Zazzi M. andBoucher C. A. B. on behalf of the European Consensus Group on Clinical Management of Tropism Testing. Consensus Statement of the European Guidelines on Clinical Management of HIV-1 Tropism Testing vs 1.0. Tenth International Congress on Drug Therapy in HIV Infection. Glasgow, UK, 2010.


55. Demetriou V. L., van de Vijver D. A. M. C., Kousiappa I., Balotta C., Clotet B., Grossman Z., Jørgensen L. B., Lepej S. Z., Levy I., Nielsen C., Paraskevis D., Poljak M., Roman F., Ruiz L., Schmidt J. C., Vandamme A. M., Vercauteren J. and Kostrikis L. G. Quantification of M-group HIV-1 Cellular DNA Load in Newly-Diagnosed Treatment-Naïve Patients in Europe: Lack of Correlation with Transmitted Resistance to Antiretroviral Drugs. XVIII International AIDS Conference. Vienna, Austria, 2010.


56. Hadjinicolaou A., Demetriou V. and Kostrikis L. G. Molecular Beacon Probes: A New Tool for Fast and Accurate Detection of Infectious Agents. 17th International Student Congress of Medical Sciences, Grotigen, Netherlands, 2010.


57. Demetriou V. L., Kousiappa I. and Kostrikis L. G. Molecular Epidemiology of HIV and HCV in Co-Infected Individuals in Cyprus. 6th Internationals Workshop on HIV and Hepatitis Co-Infection. Tel Aviv, Israel, 2010.


58. Demetriou V. L., Loizidou E. Z. and Kostrikis L. G. Implications of HCV Natural Genetic Diversity on HCV NS5B Nucleoside Inhibitor NM283. 8th European HIV Drug Resistance Workshop. Sorrento, Italy, 2010.


59. Demetriou V. L., van de Vijver D. A. and Kostrikis L. G. Molecular Characterization of HCV Strains from Cypriot IV Drug Users Reveals Multiple Introductions and Epidemiologically Related Transmission-Clusters. 8th European HIV Drug Resistance Workshop. Sorrento, Italy, 2010.


60. Demetriou V., and Kostrikis L. G. Implications of HCV Natural Genetic Diversity on HCV NS5B Inhibitor NM283. 16th International Symposium on HIV and Emerging Infectious Diseases. Marseille, France, 2010.


61. Loizidou E., and Kostrikis L. G. HIV-1 Integrase Inhibitors: Role of Natural Diversity on Drug Efficacy and Resistance. 2nd International Conference on Drug Discovery and Therapy. Dubai, United Arab Emirates, 2010.


62. Loizidou E., Kousiappa I., Zeinalipour-Yazdi C., Christophides T., Van de Vijver D. and Kostrikis L. G. Computational Analysis of the Binding Parameters of HIV-1 Intergrase Inhibitors and Correlation to Resistance Development. 12th European AIDS Conference. Cologne, Germany, 2009.


63. Demetriou V. L., van de Vijver D. A., Hezka J., Georgiades N., Savvopoulou N., Charilaou C. C., Argyriou A., Pavlou T., Platritis K., Veresies K. L., and Kostrikis L. G. Molecular Epidemiology of Hepatitis C Infection among Intravenous Drug Users Seeking Therapy in Cyprus. 16th International Symposium on Hepatitis C Virus and Related Viruses. Nice, France, 2009.


64. van de Vijver D. A. M. C., Wensing A. M. J., Vercauteren J., Albert J., Balotta C., Hamouda O., Kücherer C., Struck D., Schmit J. C., Asjo B., Bruckova M., Camacho R., Clotet B., Coughlan S., Grossman Z., Horban A., Korn K., Kostrikis L. G., Nielsen C., Paraskevis D., Poljak M., Puchhammer-Stockl E., Riva C., Ruiz L., Salminen M., Schuurman R., Sonnerborg A., Stanekova D., Stanojevic M., and Boucher C. A. B. on behalf of the SPREAD-Programme. Phylogenetic Analysis of Viral Sequences among Patients Newly Diagnosed with HIV across Europe Indicates that Most Infections Occur within Single Countries. 5th IAS, Cape Town, South Africa, 2009.


65. Kousiappa I., Van de Vijver D., and Kostrikis L. G. Near-Full Genetic Analysis of HIV-1 Sequences Derived from Cyprus: Evidence of a High Polyphyletic and Evolving Infection. 7th European HIV Drug Resistance Workshop, Stockholm, Sweden, 2009.


66. Loizidou E., Zeinalipour-Yazdi C., Van de Vijver D., and Kostrikis L. G. Structure-Based Computational Analysis of the Implications of Subtype Specific Polymorphisms on the Efficacy of Integrase Inhibitors. 7th European HIV Drug Resistance Workshop, Stockholm, Sweden, 2009.


67. Demetriou V. and Kostrikis L. G. Quantitation of HV-1 Cellular DNA Viral Load in Newly Diagnosed Drug Naïve Patients in Europe. 7th EuropeHIVResistance (EHR) Meeting, Utrecht, Netherlands, 2008. (Oral presentation)


68. Loizidou E., Dikaiakos M., Nicolaides A., Nicolaou C., Pattichis C., Promponas V. and Kostrikis L. G. Drug Development for Non-B HIV-1 Strains. XVII International AIDS Conference, Mexico City, Mexico, 2008.


69. Loizidou E. Z., Kousiappa I., Themistokleous G., Zeinalipour-Yazdi C. D. and Kostrikis L. G. Genetic Analysis of HIV-1 Integrase within Primary M Group Strains: In-Silico Structural Analysis of Subtype Specific Polymorphisms on Integrase Inhibitor Efficacy. XVII International HIV Drug Resistance Workshop: Basic Principles and Clinical Implications, Sitges, Spain, 2008.


70. Kousiappa I., Van de Vijver D., Demetriades I. and Kostrikis L. G. Molecular Epidemiology and Drug Resistance Genotypic Analysis of Strains from Patients Infected with Human Immunodeficiency Virus Type 1 (HIV-1) in Cyprus. 15th International Symposium on HIV and Emerging Infectious Diseases, Tulon, France, 2008.


71. Abecasis A. B., Wensing A. M. J., Paraskevis D., Vercauteren J., van de Vijver D. A., Albert J., B Asjo6, Balotta C., Bruckova M., Camacho R., Coughlan S., Grossman Z., Hamouda O., Horban A., Korn K., Kostrikis L.G., Kücherer C., Nielsen C., Poljak M., Puchhammer-Stockl E., Riva C., Ruiz L., Salminen M., Schmit J. C., Schuurman R., Sonnerborg A, Stanekova D., Stanojevic M., Struck D., Boucher C. A. B. and Vandamme A. M., on behalf of the SPREAD-Programme. Quantitation of HIV-1 Cellular Viral Load Within HIV-1 Group M Strains: Implications of Cellular Viral Load and Resistance. 6th European HIV Resistance Workshop, Budapest, Hungary, 2008.


72. Kostrikis L. G. and Loizidou E. Z. De novo Design of HIV-1 Integrase Inhibitors. 1st International Conference on Drug Design and Discovery, Dubai, United Arab Emirates, 2008.


73. Demetriou V. L. and Kostrikis L. G. Quantitation of HIV-1 Cellular Viral Load Within HIV-1 Group M Strains: Implications of Cellular Viral Load and Resistance. 4th EuropeHIVResistance (EHR) Meeting, Zeist, Netherlands, 2007. (Oral Presentation)


74. Kousiappa I. and Kostrikis L. G. Molecular Epidemiology and Drug Resistance in Cyprus 2003-2006. 4th EuropeHIVResistance (EHR) Meeting, Zeist, Netherlands, 2007. (Oral Presentation)


75. Demetriou V. L., Vounou-Hadjigeorgiou E., Koliou-Mazeri M., Papakyriakou P., Petsas L., Potamitis G., Chemonides S. and Kostrikis G. L. Genetic Analysis of Hepatitis C Virus (HCV) from patients in Cyprus: Evidence of Genotypic Heterogeneity Including the Presence of Two Recombinant Strains. 27th Greek National Congress of Gastroenterology, Salonika, Greece, 2007.


76. Kousiappa I., Van de Vijver D., Gilliland S., Demetriades I. and Kostrikis L.G. Epidemiology and Genotypic Analysis of Drug Resistant Strains from Naïve Patients Infected with Human Immunodefiencincy Virus Type 1 (HIV-1) in Cyprus. 5th European HIV Drug Resistance Workshop, Cascais, Portugal, 2007.


77. Kousiappa I., Giantsiou-Kyriakou A., Yiakoumi E., Demetriou V., Kostrikis L.G. Genetic Analysis of the Env Gene of HIV Isolates from Patients in Cyprus from 1994 until 2005: Evidence of a Highly Evolving Epidemic. 12th International Bioinformatics Workshop on Virus Evolution and Molecular Epidemiology, Athens, Greece, 2006.


78. Demetriou V. L., The Cyprus Hepatitis C Network and Kostrikis L. G. Epidemiological Analysis of the Hepatitis C Virus Infection in Cyprus. 12th International Bioinformatics Workshop on Virus Evolution and Molecular Epidemiology, Athens, Greece, 2006.


79. Kostrikis L.G. Host and Viral Correlates of HIV-1 Transmission and Disease Progression. US National Institute of Health 2006 NIAID Research Conference, Opatija, Croatia, 2006.


80. Kousiappa I., Giantsiou-Kyriakou A., Yiakoumi E., Demetriou V., Kostrikis L.G. Genetic Analysis of the Env Gene of Human Immunodeficiency Virus Type 1 (HIV-1) Strains from Patients in Cyprus from 1994 until 2005: Evidence of a Highly Evolving Epidemic. 14th International Symposium on HIV and Emerging Infectious Diseases, Tulon, France, 2006.


81. Kostrikis L.G. Multi-Allelic Detection of the Severe Acute Respiratory Syndrome-Associated Coronavirus (SARS-CoV) Using ‘Sloppy’ Molecular Beacons: A ‘Molecular Shotgun’ Approach of Recognizing a Moving Genetic Target. 8th Hellenic Symposium of Virology, Thessalonica, Greece, 2006.


82. Kousiappa I., Giantsiou-Kyriakou A., Yiakoumi E., Kostrikis L.G. Γενετική Ανάλυση της Περιοχής C2-C5 του Γονιδίου Env από Στελέχη του ιού της ανθρώπινης ανοσοανεπάρκειας τύπου 1 (HIV1) σε Ασθενείς στην Κύπρο από το 1994 έως και το 2005. 8th Hellenic Symposium of Virology, Thessalonica, Greece, 2006.


83. Kostrikis L.G. Implications of Cellular HIV-1 DNA Load in Disease Progression and Efficacy of Antiretroviral Therapy. 2nd International Workshop on HIV Persistence During Therapy, Saint Martin, French West Indies, 2005.


84. Papantoniou C, Demetriades, Wensing A. M. J., van Rooijen W. J. M., Chu M. L. J. N., Kostrikis L.G. Genetic Analysis of HIV-1 Isolates from Drug-Naïve Patients in Cyprus: High Prevalence of HIV non-B Subtypes and Spread of Drug-Resistance. 3rd European HIV Drug Resistance Workshop, Athens, Greece, 2005.


85. L. G. Kostrikis. Multi-allelic Detection of the Severe Acute Respiratory Syndrome-associated Coronavirus Using ‘Sloppy’ Molecular Beacons: A ‘Molecular Shotgun’ Approach of Recognizing a Moving Target. 13th International Symposium on HIV & Emerging Infectious Diseases, Tulon, France, 2004.


86. L. G. Kostrikis. Impact of HIV-1 Cellular Viral Load on the Progression of HIV-1 Disease. 1st International Workshop on HIV Persistence during Therapy, Saint Martin, USVI, 2003.


87. Hatzakis A., Touloumi G., Pantazis N., Anastassopoulou C., Katsarou O., Karafoulidou A., Goedert J. J., Kostrikis L. G. Cellular HIV-1-DNA Load Predicts the Outcome of Highly Active Antiretroviral Therapy (HAART). 2nd IAS Conference on Pathogenesis and Treatment, Paris, France, 2003.


88. Kostrikis L. G. Rapid Molecular Identification of Pathogenic Agents: Detection of Bacillus anthracis (anthrax) Strains in Clinical Samples. 4th Biomedical Symposium, Limassol, Cyprus, 2003.


89. Kostrikis L. G., Touloumi G., Karanicolas R., Pantazis N., Anastassopoulou C., Karafoulidou A., Goedert J., Hatzakis A. Quantitation of HIV-1 DNA Forms with the Second Template Switch (HIV-1 STS DNA) in Peripheral Blood Predicts Disease Progression in HIV-1 Infection Independently of Plasma RNA Load. XIV International AIDS Conference, Barcelona, Spain, 2002. (Selected for oral presentation)


90. Metzner K. J., Bonhoeffer S., Fischer M., Karanicolas R., Weber R., Hirschel B., Kostrikis L. G., Günthard H. F. Detection of Minor Populations of Drug-Resistant-Viruses in Patients Undergoing Structured Treatment Interruptions. XI International HIV Drug Resistance Workshop, Seville, Spain. Antiviral Therapy 7: S1, 2002. (Selected for oral presentation)


91. Barboushe R., Hong L., Dellagi K., Kostrikis L. G. Contrasting Frequencies of 32-CCR5 and CCR2-V64I Alleles in the Tunisian Population. The 1ST IAS conference on HIV Pathogenesis and Treatment, Buenos Aires, Argentina, 2001.


92. Touloumi G., Karanicolas R., Pantazis N., Karafoulidou A., Mandalaki T., Goedert J. J., Kostrikis L. G., Hatzakis A. Analysis of Longitudinal T-cell Excision DNA Levels in HIV-1 Infected Subjects pre- and post-HAART. The 8th European Conference on Clinical Aspects and Treatment of HIV-Infection, Athens, Greece, 2001.


93. Gao F., Li Y., Trask S., Chen Y., Kostrikis L. G., Ho D. D., Oh M., Vidal N., Shaw G., Hahn B., Peeters M. Evidence for Distinct Sub-subtypes within HIV-1 Subtype A. The 8th Conference on Retroviruses and Opportunistic Infections, Chicago, USA, 2001.


94. Kramer T., Touloumi G., Karanicolas R., Pappa M., Pollack H., Palumbo P., Kostrikis L. G. Effect of Recent Thymic Emigrants on Progression of HIV-1 Disease Among Children with Perinatal HIV-1 Infection. The 8th Conference on Retroviruses and Opportunistic Infections, Chicago, USA, 2001. (Selected for oral presentation)


95. Valentin A., Rosati M., Patenaude D., Yarchoan R., Kostrikis L. G., A. Hatzakis A., and Pavlakis G. N. Natural Killer Cells Are Targets for HIV-1 Infection in Vivo: Use of Real-Time PCR for the Quantification of Cell-Associated Viral Load. AIDS Vaccine 2001 Conference, Philadelphia, USA, 2001.


96. Metzner K. J., Moretto W. J., Gettie A., Binley J. M., Ho D. D., Marx P. A., Kostrikis L. G., Nixon D. F., Connor R. I. Impact of in vivo CD8+ T Cell Depletion on Rechallenge with Pathogenic SIV in Rhesus Macaques Immunized with a Live, Attenuated SIV Vaccine. 18th Annual Symposium on Nonhuman Primate Models for AIDS, Wisconsin, USA, 2000.


97. Gao F., Li Y., Trask S. A., Chen Y., Kostrikis L. G., Ho D. D., Oh M., Peeters M., Hahn B. H. New Genetic Variants of HIV-1. US-Japan cooperative medical science program Twelfth joint scientific meeting of the AIDS Panel Santa Fe, New Mexico, 2000.


98. Sharkey M., Teo I., Greenough T., Sharova N., Luzuriaga K., Sullivan J. L., Bucy P., Kostrikis L. G., Davaro R., Cheeseman S., Daly J., Bova C., Ellison D., Mady B., Lai K. K., Moyle G., Nelson M., Gazzard B., Stevenson M. Persistence of Episomal HIV-1 Infection Intermediates in the Face of HAART and Sustained, Undetectable HIV-1 RNA. The 7th Conference on Retroviruses and Opportunistic Infections, San Fransisco, USA, 2000.


99. Metzner K., Jin X., Lee F., Gettie A., Daily P., Ho D. D., Marx P., Kostrikis L. G., Connor R. Effects on in vivo CD8-Depletion on the Control of Virus Replication in Rhesus macaques Immunized with a Live, Attenuated SIV Vaccine and Protected from Pathogenic SIV. The 7th Conference on Retroviruses and Opportunistic Infections, San Francisco, USA, 2000.


100. Hatzakis A., Touloumi G., Karafoulidou A., Mandalaki T., Karanicolas R., Anastassopoulou C., Zhang L., Goedert J. J., Ho D. D., Kostrikis L. G. Effect of Recent Thymic Emigrants on HIV-1 Disease Progression. The 7th Conference on Retroviruses and Opportunistic Infections, San Francisco, USA, 2000.


101. Metzner K., Jin X., Gettie A., Daily P., Ho D. D., Marx P., Kostrikis L. G., Connor R. Effects on in vivo CD8-Depletion on the Control of Virus Replication in Rhesus macaques Immunized with a Live, Attenuated SIV Vaccine and Protected from Pathogenic SIV. 17th Annual Symposium on Nonhuman Primate Models for AIDS, New Orleans, Louisiana, USA, 1999.


102. Kostrikis L. G., Neuman A. U., Thompson B., Lew J. F., McIntosh K, Pollack H., Palumbo P., Ho D. D., Moore J. P. Polymorphisms in the Regulatory Region of the CCR5 Infuence Perinatal Transmission of HIV. Teratology Society: HIV Infection During Pregnancy, Keystone, Colorado, USA, 1999.


103. Lewin S., Zhang, L., Kostrikis L.G., Karanicolas R., Skulsky E., Vesamen M., Hurley A., Ramratnam B., Kost R., Markowitz M., Ho D.D. The Impact of HIV Infection on the Number of Recent Thymic Emigrants in Blood and the Effect of HAART. The 6th Conference on Retroviruses and Opportunistic Infections, Chicago, USA, 1999.


104. Zhang, L., Lewin S., He Y., Lin H., Tuttleton S., Skulsky E., Karanicolas R., Spiegel H., Borkowsky W., Kostrikis L.G., Ho D.D. Quantifying Recent Thymic Emigrants (RTE) in Blood of >400 Normal Persons with a Real-Time PCR/Molecular Beacon Assay for T-Cell Receptor (TCR) Excisional Circles (TREC).The 6th Conference on Retroviruses and Opportunistic Infections, Chicago, USA, 1999.


105. Paxton W., Neumann A., Brown C., Deutsch L., Kang S., Kostrikis L. G., Ho D. D., Koup R., Wolinsky S. High RANTES Production from CD4+ Cells Correlates with Slower Progression to AIDS and with CCR5-Δ32 Heterozygosity. The 6th Conference on Retroviruses and Opportunistic Infections, Chicago, USA, 1999.


106. Lewin S., Vesamen M., Kostrikis L. G., Zhang L., Ho D. D., Markowitz M. The Use of Real-Time PCR to Quantify HIV Unspliced (US) mRNA in Patients on Effective Antiretroviral Therapy. The 6th Conference on Retroviruses and Opportunistic Infections, Chicago, USA, 1999.


107. Kostrikis L. G., Martinson J. R. Global Distribution of the CCR2-64I/CCR5-59653-T HIV Disease-Protective Haplotype. The 6th Conference on Retroviruses and Opportunistic Infections, Chicago, USA, 1999.


108. Kostrikis L. G., Neuman A. U., Thompson B., Lew J. F., McIntosh K, Pollack H., Palumbo P., Ho D. D., Moore J. P. Polymorphisms in the Regulatory Region of the CCR5 Influence Perinatal Transmission of HIV. The 6th Conference on Retroviruses and Opportunistic Infections, Chicago, USA, 1999. (Selected for oral presentation)


109. Kostrikis L. G., Huang Y., Neumann A. U., Moore J. P., Ho D. D. Molecular Beacon-Based Real-time PCR for Automated Detection of Point Mutations in Human Alleles: The Implications of Polymorphisms in the Regulatory Region of the CCR5 in HIV-1 Transmission and Pathogenesis. Keystone Symposia: HIV Pathogenesis and Treatment, Park City, Utah, USA, 1998.


110. Robbins K. E., Kostrikis L.G., Brown T. M., Anzala O., Shin S., Plummer F. A., Ho D. D., Kalish M. L. Changing Human Immunodeficiency Virus Type 1 Subtypes in Kenya as Determined by DNA sequencing and the Combinatorial Melting Assay (COMA). Keystone Symposia: HIV Pathogenesis and Treatment, Park City, Utah, USA, 1998.


111. Kostrikis L. G., Ho D. D., Moore J. P. The Effect of Polymorphisms in the Regulatory Regions of the CCR5 Promoter on HIV-1 Vertical Transmission and on Disease Progression in Infected Children. Keystone Symposia: HIV Pathogenesis and Treatment, Park City, Utah, USA, 1998.


112. Gao F., Robertson D. L., Carruthers C. D., Li Y., Kostrikis L. G., Ho D. D., Hahn B. H. Evidence for Quadruple Recombination Between Subtypes A, C, G, and I in an HIV-1 Isolate from Cyprus. The 5th Conference on Retroviruses and Opportunistic Infections, Chicago, USA, 1998.


113. Moore J. P., Kostrikis L. G., Ho D. D. The Effect of Polymorphisms in the Regulatory Regions of the CCR5 Promoter on HIV-1 Vertical Transmission and on Disease Progression in Infected Children. Conference on Retroviruses and Opportunistic Infections, Chicago, USA, 1998.


114. Kostrikis L. G., Shin S., Ho D. D. Genetic Homologies of HIV-1 and HCV Strains Determined with Differential Melting of Combinatorial DNA Arrays. The 5th Conference on Retroviruses and Opportunistic Infections, Chicago, USA, 1998.


115. Kostrikis L. G. and Ho D. D. Implications of Genetic Variation of Human Immunodeficiency Virus Type 1 in Vaccine Development. The 4th World Biomedical Conference of the Hellenic Diaspora, Nicosia, Cyprus, 1996.


116. Kostrikis L.G., Bagdades E., Dimitriou D., Ho D. D. Molecular Epidemiology of HIV-1 Infection in Cyprus: Identification of a New subtype (I). The First National Symposium on AIDS and Sexually Transmitted Diseases, Thessaloniki, Greece, 1996.


117. Kostrikis L. G., Cao Y., Ngai H., Moore J. P., Bradac J. and Ho D. D. Lack of Direct Correlation between Neutralization Serotypes and Genetic Subtypes of HIV-1. Keystone Symposia: Prevention and Treatment of AIDS, Hilton Head Island, USA, 1996.


118. Bradac J., Cao Y., Leu J., Qin L., Ngai H., Kostrikis L. G., Moore J. P., Ho D. D. Inter- and Intra- Subtype Neutralization of Human Immunodeficiency Virus Type 1: Implications for Vaccine Development. The Tenth Cent-Gardes Symposium on Retroviruses of Human AIDS and Related Human Diseases, Marnes-La-Coquette, France, 1995.


119. Kostrikis L. G., Bagdades E., Cao Y., Zhang L., Dimitriou D., Ho D. D. Genetic Analysis of Human Immunodeficiency Virus Type-1 from Patients in Cyprus: Identification of a New Subtype (I). Keystone Symposia: HIV Pathogenesis, Keystone, CO. J. Cell. Biochem. 19D, 430, 1995.


120. Kostrikis L. G., Ho D. D. Immunity to HIV-1 Antigens Displayed on the Surface of Inoviruses. Keystone Symposia: Prevention and Treatment of AIDS, Hilton Head Island, SC. J. Cell. Biochem. 18B, 157, 1994.


121. Kostrikis L. G., Liu D. J., Day L. A. Hyperchromicity of DNA and Tyrosines in Pf1 Filamentous Virus. Biophysical Society Meeting (U.S), Washington, D.C. Biophys. J. 64 (2), 189, 1993.


122. Day L. A., Kostrikis L. G., Kim H.-Y., Marzec C. J. Structure Variability of Filamentous Bacterial Viruses. 15th International Congress of Biochemistry. Jerusalem, Israel, 1991.


123. Kostrikis L. G., Reisberg S. A., Day L. A. Transfection of E. coli by Pf1 Viral RF-DNA produces Epf1, a Virus with a Structure Like Pf1 that Infects Pseudomonas aeruginosa. Biophysical Society Meeting (U.S), San Francisco, CA. Biophys. J. 59, 2831, 1991.